search
Back to results

The Effect of Olive Leaf Extract on Blood Pressure in Overweight Prehypertensives

Primary Purpose

Hypertension

Status
Completed
Phase
Not Applicable
Locations
New Zealand
Study Type
Interventional
Intervention
Olive leaf extract liquid
Sponsored by
University of Reading
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional prevention trial for Hypertension

Eligibility Criteria

18 Years - 65 Years (Adult, Older Adult)MaleAccepts Healthy Volunteers

Inclusion Criteria:

Men 18-65 years; Non-smokers; Prepared to consume olive leaf extract liquid Systolic blood pressure 121-139 mmHg and diastolic blood pressure 81-89 mmHg Body mass index (BMI) between 25-30 kg/m2 or waist >102 cm

Exclusion Criteria:

Smokers Using blood pressure, lipid lowering, thyroid disorder, blood clotting medication Using supplements or functional foods that will affect lipid concentrations (e.g. sterol enriched spreads) Chronic disease e.g. CHD, diabetes, cancer, digestive disorders Individuals who are unwilling to refrain from consuming olive containing products for the duration of the study

Sites / Locations

  • Institute of Food, Nutrition and Human Health, Massey University

Arms of the Study

Arm 1

Arm 2

Arm Type

Active Comparator

Placebo Comparator

Arm Label

Olive leaf extract liquid

Placebo liquid

Arm Description

20ml of polyphenol-rich olive leaf extract liquid to be consumed daily for 6 weeks

20ml of polyphenol-free placebo liquid (containing water, glycerin, flavours, colours and aromas) to be consumed daily for 6 weeks

Outcomes

Primary Outcome Measures

Blood pressure measured via 24 hour ambulatory blood pressure monitors

Secondary Outcome Measures

Vascular function assessed by pulse wave velocity (PWV)
Lipid profile measured via serum assay
Inflammatory cytokines measured via plasma assay
Fructosamine measured via plasma assay
Glucose measured via plasma assay
Nitric oxide measured via plasma assay
Insulin measured via plasma assay
Haemostatic factors (D-dimer, PAI-1 ag, von Willebrand factor, prothrombin F1+2, factor VIII) measured via plasma assay
Oxidised LDL measured via plasma assay
Obesity markers (adiponectin, CCL-2, complement factor D, CRP, IL-6, IL-10, leptin, resistin, serpin E1 and TNF-a) measured via plasma assay

Full Information

First Posted
February 20, 2013
Last Updated
October 10, 2013
Sponsor
University of Reading
Collaborators
Massey University
search

1. Study Identification

Unique Protocol Identification Number
NCT01796561
Brief Title
The Effect of Olive Leaf Extract on Blood Pressure in Overweight Prehypertensives
Official Title
Effect of Chronic Polyphenol-rich Olive Leaf Extract Intake on Cardiovascular Risk Markers
Study Type
Interventional

2. Study Status

Record Verification Date
October 2013
Overall Recruitment Status
Completed
Study Start Date
February 2013 (undefined)
Primary Completion Date
October 2013 (Actual)
Study Completion Date
October 2013 (Actual)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
University of Reading
Collaborators
Massey University

4. Oversight

Data Monitoring Committee
Yes

5. Study Description

Brief Summary
Cardiovascular disease (CVD) is the leading cause of death in New Zealand (40% of all deaths). 37% of New Zealanders suffer from high blood pressure (World Health Organisation 2008 figures), a well established modifiable risk factor for CVD. Above 115/75 mmHg, CVD risk doubles for each increment of 20/10 mmHg that blood pressure is raised. An increase in BMI and waist circumference has been associated with an increase in blood pressure. The leaves of the olive plant are rich in plant compounds known as polyphenols. This particular group of polyphenols are known secoiridoids, which are also present in olive oil and olives though at lower concentrations, are only found in this family of plants. Diets high in polyphenols have been found to reduce the risk of chronic diseases. Studies have shown that consumption of phenolic-rich olive leaf extract (OLE) can significantly reduce blood pressure in individuals suffering from high blood pressure (hypertension), with the magnitude of effect being comparable to a commonly used antihypertensive drug. In such trials OLE also resulted in an improved blood lipid (a reduction in total and LDL cholesterol and triacylglycerides) which also reduces CVD risk. One study testing the effect of OLE on individuals with mild or prehypertension (i.e. those with systolic blood pressure in the range 121-139 mmHg and diastolic blood pressure in the range 81-89 mmHg but not taking antihypertensive medication) also found these same improvements. OLE has been indicated to have the potential to improve other cardiovascular risk markers such as vascular function, inflammation, platelet aggregation, oxidation of LDL and glucose tolerance however much of this evidence is derived from animal, in vitro and ex vivo studies and so well designed and controlled human studies are required to verify that these findings are applicable to humans. Therefore OLE supplementation may be a useful dietary strategy for reducing CVD risk in a cohort of overweight prehypertensive individuals. The aim of the study is to determine the effect of OLE intake on blood pressure and other CVD risk markers in overweight subjects with mild hypertension and to link any study outcomes with the presence of OLE phenolics in urine

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Hypertension

7. Study Design

Primary Purpose
Prevention
Study Phase
Not Applicable
Interventional Study Model
Crossover Assignment
Masking
ParticipantCare ProviderInvestigatorOutcomes Assessor
Allocation
Randomized
Enrollment
60 (Actual)

8. Arms, Groups, and Interventions

Arm Title
Olive leaf extract liquid
Arm Type
Active Comparator
Arm Description
20ml of polyphenol-rich olive leaf extract liquid to be consumed daily for 6 weeks
Arm Title
Placebo liquid
Arm Type
Placebo Comparator
Arm Description
20ml of polyphenol-free placebo liquid (containing water, glycerin, flavours, colours and aromas) to be consumed daily for 6 weeks
Intervention Type
Dietary Supplement
Intervention Name(s)
Olive leaf extract liquid
Intervention Description
Commercially available polyphenol-rich olive leaf extract liquid
Primary Outcome Measure Information:
Title
Blood pressure measured via 24 hour ambulatory blood pressure monitors
Time Frame
6 weeks
Secondary Outcome Measure Information:
Title
Vascular function assessed by pulse wave velocity (PWV)
Time Frame
6 weeks
Title
Lipid profile measured via serum assay
Time Frame
6 weeks
Title
Inflammatory cytokines measured via plasma assay
Time Frame
6 weeks
Title
Fructosamine measured via plasma assay
Time Frame
6 weeks
Title
Glucose measured via plasma assay
Time Frame
6 weeks
Title
Nitric oxide measured via plasma assay
Time Frame
6 weeks
Title
Insulin measured via plasma assay
Time Frame
6 weeks
Title
Haemostatic factors (D-dimer, PAI-1 ag, von Willebrand factor, prothrombin F1+2, factor VIII) measured via plasma assay
Time Frame
6 weeks
Title
Oxidised LDL measured via plasma assay
Time Frame
6 weeks
Title
Obesity markers (adiponectin, CCL-2, complement factor D, CRP, IL-6, IL-10, leptin, resistin, serpin E1 and TNF-a) measured via plasma assay
Time Frame
6 weeks

10. Eligibility

Sex
Male
Minimum Age & Unit of Time
18 Years
Maximum Age & Unit of Time
65 Years
Accepts Healthy Volunteers
Accepts Healthy Volunteers
Eligibility Criteria
Inclusion Criteria: Men 18-65 years; Non-smokers; Prepared to consume olive leaf extract liquid Systolic blood pressure 121-139 mmHg and diastolic blood pressure 81-89 mmHg Body mass index (BMI) between 25-30 kg/m2 or waist >102 cm Exclusion Criteria: Smokers Using blood pressure, lipid lowering, thyroid disorder, blood clotting medication Using supplements or functional foods that will affect lipid concentrations (e.g. sterol enriched spreads) Chronic disease e.g. CHD, diabetes, cancer, digestive disorders Individuals who are unwilling to refrain from consuming olive containing products for the duration of the study
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Welma Stonehouse, PhD
Organizational Affiliation
Massey University
Official's Role
Principal Investigator
Facility Information:
Facility Name
Institute of Food, Nutrition and Human Health, Massey University
City
Albany, North Shore
State/Province
Auckland
ZIP/Postal Code
0745
Country
New Zealand

12. IPD Sharing Statement

Learn more about this trial

The Effect of Olive Leaf Extract on Blood Pressure in Overweight Prehypertensives

We'll reach out to this number within 24 hrs